No bankruptcy on account of the raised capital yet the to-go brand model is clearly flawed. This company needs to become a actual biotech company and focus on it's drugs. If they ever get their excellegan to sell and use that money to actually move generex. Than and only then will this company be a buy but until that day occurs, its a hold.
When a company has pipeline and does R&D for drugs i don't care what you call yourself you are what you are and thats a biotech company. Management needs to be destroyed and rebuilt such a promising company with idiots running it. I'm not arguing with you hung i understand your point is to troll the truth i'm just stating my opinion